Physician profile
Vikas Satyananda
NPI 1467893727
$3,186.25
in general payments reported to CMS, 2019-2025
8 companies · $3,013 in 2025
The $3,013 reported for 2025 was more than what 86% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.08 · 2021: $150 · 2024: $2.62 · 2025: $3,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,318 · Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,318.07 |
| Food and Beverage | $697.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,547.90 | 2025 | Neuwave |
| Intuitive Surgical, INC. | $158.21 | 2021-2025 | |
| Histosonics, INC. | $150.28 | 2025 | |
| Intera Oncology, INC | $118.40 | 2025 | Intera |
| Galvanize Therapeutics, INC | $91.60 | 2025 | Aliya System |
| Ethicon US, LLC | $77.11 | 2025 | Dermabond Prineo, Stratafix, Ethicon |
| Regeneron Healthcare Solutions, INC. | $21.67 | 2025 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $21.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Satyananda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.